Baghel Kalpana, Khan Aamir, Kango Naveen
Department of Microbiology, School of Biological Sciences, Dr Harisingh Gour Vishwavidyalaya (A Central University), Sagar, MP, India.
Department of Zoology, School of Biological Sciences, Dr Harisingh Gour Vishwavidyalaya (A Central University), Sagar, MP, India.
J Diet Suppl. 2024;21(5):677-708. doi: 10.1080/19390211.2024.2340509. Epub 2024 Apr 15.
Diabetes is a metabolic disorder whose prevalence has become a worrying condition in recent decades. Chronic diabetes can result in serious health conditions such as impaired kidney function, stroke, blindness, and myocardial infarction. Despite a variety of currently available treatments, cases of diabetes and its complications are on the rise. This review article provides a comprehensive account of the ameliorative effect of prebiotics and probiotics individually or in combination i.e. synbiotics on health complications induced by Type 2 Diabetes Mellitus (T2DM). Recent advances in the field underscore encouraging outcomes suggesting the consumption of synbiotics leads to favorable changes in the gut microbiota. These changes result in the production of bioactive metabolites such as short-chain fatty acids (crucial for lowering blood sugar levels), reducing inflammation, preventing insulin resistance, and encouraging the release of glucagon-like peptide-1 in the host. Notably, novel strategies supplementing synbiotics to support gut microbiota are gaining attraction as pivotal interventions in mitigating T2DM-induced health complications. Thus, by nurturing a symbiotic relationship between prebiotics and probiotics i.e. synbiotics, these interventions hold promise in reshaping the microbial landscape of the gut thereby offering a multifaceted approach to managing T2DM and its associated morbidities. Supporting the potential of synbiotics underscores a paradigm shift toward holistic and targeted interventions in diabetes management, offering prospects for improved outcomes and enhanced quality of life for affected individuals. Nevertheless, more research needs to be done to better understand the single and multispecies pre/pro and synbiotics in the prevention and management of T2DM-induced health complications.
糖尿病是一种代谢紊乱疾病,近几十年来其患病率已成为令人担忧的状况。慢性糖尿病可导致严重的健康问题,如肾功能损害、中风、失明和心肌梗死。尽管目前有多种治疗方法,但糖尿病及其并发症的病例仍在增加。这篇综述文章全面阐述了益生元、益生菌单独或联合使用(即合生元)对2型糖尿病(T2DM)引发的健康并发症的改善作用。该领域的最新进展突出了令人鼓舞的成果,表明食用合生元会使肠道微生物群产生有利变化。这些变化会导致生物活性代谢产物的产生,如短链脂肪酸(对降低血糖水平至关重要)、减轻炎症、预防胰岛素抵抗,并促进宿主释放胰高血糖素样肽-1。值得注意的是,补充合生元以支持肠道微生物群的新策略正作为缓解T2DM引发的健康并发症的关键干预措施而受到关注。因此,通过培养益生元和益生菌之间的共生关系(即合生元),这些干预措施有望重塑肠道微生物格局,从而为管理T2DM及其相关疾病提供多方面的方法。支持合生元的潜力凸显了糖尿病管理向整体和靶向干预的范式转变,为改善受影响个体的治疗效果和提高生活质量带来了希望。然而,仍需要进行更多研究,以更好地了解单一和多种益生元/益生菌及合生元在预防和管理T2DM引发的健康并发症中的作用。